Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report

doi:10.12998/wjcc.v10.i31.11617

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2838)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

120

WORD

HTML

1371

Figures (1-5)

322

Tables (1-1)

211

Sum=2049

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

263

Download

526

Sum=789

Nov 6, 2022 (publication date) through Sep 1, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Nov 6, 2022; 10(31): 11617-11624
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11617

Full Size Figure Download Figure

Figure 2 Immunohistochemistry. A: Immunohistochemical (IHC) staining for programmed death-1 (PD-1) revealed positive neoplastic cells with a membranous pattern (× 200, scale bar: 100 μm); B: IHC staining for PD-1 revealed negative neoplastic cells (× 200, scale bar: 100 μm); C-F: IHC staining for mismatch repair (MMR) proteins revealed integrity of the MMR system (× 200, scale bar: 100 μm).

Citation: Zeng SY, Yuan J, Lv M. Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report. World J Clin Cases 2022; 10(31): 11617-11624
URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11617.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11617